Friday, April 1, 2022

Scientific consortium provides real-time risk assessment of SARS-CoV-2 variants on immune protection

A new program has been set up to provide a real-time risk assessment of variants of SARS-CoV-2, the virus that causes COVID-19. The program assesses how the variants might affect transmission, virulence, and resistance to both disease-induced (convalescent) and vaccine-induced immunity.

from Top Health News -- ScienceDaily https://ift.tt/O4agSyV

No comments:

Post a Comment

Scientists found a new Alzheimer’s trigger and a drug that stops it

Researchers have identified a new Alzheimer’s target and created an experimental compound that blocks a damaging process inside brain cells....